# Long-Term Follow-up of Subjects Who Were Treated With ST-920

> **NCT05039866** · — · ENROLLING_BY_INVITATION · sponsor: **Sangamo Therapeutics** · enrollment: 48 (estimated)

## Conditions studied

- Fabry Disease
- Fabry Disease, Cardiac Variant

## Interventions

- **BIOLOGICAL:** ST-920

## Key facts

- **NCT ID:** NCT05039866
- **Lead sponsor:** Sangamo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-08-16
- **Primary completion:** 2029-03
- **Final completion:** 2039-03
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05039866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05039866, "Long-Term Follow-up of Subjects Who Were Treated With ST-920". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05039866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*